JP2025120179A5 - - Google Patents
Info
- Publication number
- JP2025120179A5 JP2025120179A5 JP2025077567A JP2025077567A JP2025120179A5 JP 2025120179 A5 JP2025120179 A5 JP 2025120179A5 JP 2025077567 A JP2025077567 A JP 2025077567A JP 2025077567 A JP2025077567 A JP 2025077567A JP 2025120179 A5 JP2025120179 A5 JP 2025120179A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- immunoglobulin
- heavy chain
- region
- regions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19173633 | 2019-05-09 | ||
| EP19173633.9 | 2019-05-09 | ||
| JP2021566278A JP7760377B2 (ja) | 2019-05-09 | 2020-05-08 | タンパク質を多量体化する変異体ドメイン及びその分離 |
| PCT/NL2020/050298 WO2020226502A2 (en) | 2019-05-09 | 2020-05-08 | Variant domains for multimerizing proteins and separation thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566278A Division JP7760377B2 (ja) | 2019-05-09 | 2020-05-08 | タンパク質を多量体化する変異体ドメイン及びその分離 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025120179A JP2025120179A (ja) | 2025-08-15 |
| JP2025120179A5 true JP2025120179A5 (cg-RX-API-DMAC7.html) | 2026-02-12 |
Family
ID=66476558
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566278A Active JP7760377B2 (ja) | 2019-05-09 | 2020-05-08 | タンパク質を多量体化する変異体ドメイン及びその分離 |
| JP2025077567A Pending JP2025120179A (ja) | 2019-05-09 | 2025-05-07 | タンパク質を多量体化する変異体ドメイン及びその分離 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566278A Active JP7760377B2 (ja) | 2019-05-09 | 2020-05-08 | タンパク質を多量体化する変異体ドメイン及びその分離 |
Country Status (16)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3094318A1 (en) * | 2018-03-30 | 2019-10-03 | Merus N.V. | Multivalent antibody |
| MX2023007028A (es) * | 2020-12-18 | 2023-09-21 | Kiniksa Pharmaceuticals Ltd | Composiciones de proteínas y métodos para producir y usar las mismas. |
| MX2023015461A (es) * | 2021-06-17 | 2024-01-18 | Fapon Biotech Inc | Inmunoglobulina quimerica. |
| CN121824747A (zh) | 2022-12-27 | 2026-04-10 | 美勒斯公司 | 产生双重特异性蛋白的方法 |
| TW202544033A (zh) | 2024-04-15 | 2025-11-16 | 荷蘭商美勒斯公司 | Cd3結合結構域 |
| TW202608928A (zh) | 2024-04-30 | 2026-03-01 | 荷蘭商美勒斯公司 | 多特異性抗體藥物偶聯物 |
| TW202608927A (zh) | 2024-04-30 | 2026-03-01 | 荷蘭商美勒斯公司 | 多特異性抗體-藥物偶聯物 |
| WO2026013015A1 (en) | 2024-07-09 | 2026-01-15 | Merus N.V. | Multispecific binding moieties comprising calr and cd3 binding domains |
| WO2026018064A1 (en) | 2024-07-16 | 2026-01-22 | Merus N.V. | Multispecific multi-drug antibody-drug conjugates |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4801687A (en) | 1986-10-27 | 1989-01-31 | Bioprobe International, Inc. | Monoclonal antibody purification process using protein A |
| US5151504A (en) | 1989-11-17 | 1992-09-29 | E. R. Squibb & Sons, Inc. | Method for purification of monoclonal antibodies |
| US7135287B1 (en) * | 1999-10-02 | 2006-11-14 | Biosite, Inc. | Human antibodies |
| US6680209B1 (en) * | 1999-12-06 | 2004-01-20 | Biosite, Incorporated | Human antibodies as diagnostic reagents |
| EP1554392A4 (en) * | 2002-05-06 | 2007-08-08 | Us Gov Health & Human Serv | IDENTIFICATION OF NEW NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES WITH WIDE CROSS-REACTIVITY USING SEQUENTIAL ANTIGEN PANNING OF PHAG DISPLAY LIBRARIES |
| NZ537277A (en) | 2002-07-18 | 2008-04-30 | Crucell Holland Bv | Recombinant production of mixtures of antibodies |
| EP1542724A4 (en) * | 2002-08-19 | 2005-10-19 | Abgenix Inc | ANTIBODIES AGAINST THE MONOCYTE 1 CHIMIOATTRACTIVE PROTEIN (MCP-1) AND USES THEREOF |
| US7276585B2 (en) * | 2004-03-24 | 2007-10-02 | Xencor, Inc. | Immunoglobulin variants outside the Fc region |
| CA2595169A1 (en) * | 2005-01-12 | 2006-07-20 | Xencor, Inc. | Antibodies and fc fusion proteins with altered immunogenicity |
| JP5144499B2 (ja) * | 2006-03-31 | 2013-02-13 | 中外製薬株式会社 | 二重特異性抗体を精製するための抗体改変方法 |
| EP2471816A1 (en) | 2006-08-30 | 2012-07-04 | Genentech, Inc. | Multispecific antibodies |
| EP3127921A1 (en) * | 2007-09-26 | 2017-02-08 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substition in cdr |
| US9266967B2 (en) | 2007-12-21 | 2016-02-23 | Hoffmann-La Roche, Inc. | Bivalent, bispecific antibodies |
| US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
| US8242247B2 (en) | 2007-12-21 | 2012-08-14 | Hoffmann-La Roche Inc. | Bivalent, bispecific antibodies |
| EP3456191A1 (en) | 2008-06-27 | 2019-03-20 | Merus N.V. | Antibody producing non-human mammals |
| KR20150036824A (ko) | 2009-03-20 | 2015-04-07 | 제넨테크, 인크. | 이중특이적 항-her 항체 |
| TW201212938A (en) * | 2010-06-30 | 2012-04-01 | Novo Nordisk As | Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
| JP2014511836A (ja) * | 2011-03-25 | 2014-05-19 | グレンマーク ファーマシューティカルズ, エセ.アー. | ヘテロ二量体免疫グロブリン |
| TW201817745A (zh) * | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之FcRn結合域的治療性抗原結合分子 |
| DK2766392T3 (da) * | 2011-10-10 | 2019-10-07 | Xencor Inc | Fremgangsmåde til oprensning af antistoffer |
| BR112014010257A2 (pt) * | 2011-10-31 | 2017-04-18 | Chugai Pharmaceutical Co Ltd | molécula de ligação ao antígeno tendo conjugação regulada entre cadeias pesadas e cadeias leves |
| WO2013157953A1 (en) * | 2012-04-20 | 2013-10-24 | Merus B.V. | Methods and means for the production of ig-like molecules |
| CN104045714B (zh) * | 2013-03-14 | 2019-01-11 | 南京金斯瑞生物科技有限公司 | 曲妥珠单抗突变体IgG及其应用 |
| EP3587448B1 (en) * | 2013-03-15 | 2021-05-19 | Xencor, Inc. | Heterodimeric proteins |
| CA2941030C (en) | 2014-02-28 | 2025-05-13 | Merus N.V. | ANTIBODIES THAT BIND TO EGFR AND ERBB3 |
| EP3174897B1 (en) * | 2014-07-29 | 2020-02-12 | F.Hoffmann-La Roche Ag | Multispecific antibodies |
| MA41375A (fr) * | 2015-01-22 | 2017-11-28 | Lilly Co Eli | Anticorps igg bispécifiques et leurs procédés de préparation |
| SG11201810470XA (en) * | 2016-06-10 | 2018-12-28 | Eisai R&D Man Co Ltd | Lysine conjugated immunoglobulins |
| WO2017218698A1 (en) * | 2016-06-15 | 2017-12-21 | Sutro Biopharma, Inc. | Antibodies with engineered ch2 domains, compositions thereof and methods of using the same |
| KR20200037250A (ko) | 2017-07-06 | 2020-04-08 | 메뤼스 엔.페. | 세포에 의해 발현되는 생물학적 활성을 조절하는 항체 |
| TWI917306B (zh) | 2017-07-06 | 2026-03-11 | 荷蘭商米樂斯股份有限公司 | 藉由細胞表現之調控生物活性的結合分子 |
| TWI887193B (zh) | 2017-07-06 | 2025-06-21 | 荷蘭商米樂斯股份有限公司 | 藉由細胞表現之調控生物活性的抗體 |
| RS66708B9 (sr) | 2017-08-09 | 2025-08-29 | Merus Nv | Antitela koja se vezuju za egfr i cmet |
| WO2019148410A1 (en) * | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1 antibodies |
| WO2019148412A1 (en) * | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1/lag3 bispecific antibodies |
| CA3094318A1 (en) | 2018-03-30 | 2019-10-03 | Merus N.V. | Multivalent antibody |
| CN110272495A (zh) * | 2019-06-11 | 2019-09-24 | 南京华岩生物技术有限公司 | 一种能结合两种抗原的双特异性结合的免疫球蛋白及其用途 |
| US20240101718A1 (en) * | 2022-09-28 | 2024-03-28 | Incyte Corporation | Anti-pd-1/lag-3 bispecific antibodies and uses thereof |
-
2020
- 2020-05-08 EP EP20727737.7A patent/EP3966238A2/en active Pending
- 2020-05-08 WO PCT/NL2020/050298 patent/WO2020226502A2/en not_active Ceased
- 2020-05-08 MA MA055884A patent/MA55884A/fr unknown
- 2020-05-08 AR ARP200101330A patent/AR118898A1/es unknown
- 2020-05-08 TW TW109115418A patent/TW202108613A/zh unknown
- 2020-05-08 CN CN202210393772.0A patent/CN114702587A/zh active Pending
- 2020-05-08 CA CA3139402A patent/CA3139402A1/en active Pending
- 2020-05-08 AU AU2020268684A patent/AU2020268684C1/en active Active
- 2020-05-08 BR BR112021022405A patent/BR112021022405A2/pt unknown
- 2020-05-08 MX MX2021013646A patent/MX2021013646A/es unknown
- 2020-05-08 KR KR1020217039330A patent/KR20220017909A/ko active Pending
- 2020-05-08 PH PH1/2021/552833A patent/PH12021552833A1/en unknown
- 2020-05-08 US US16/870,715 patent/US20210054049A1/en active Pending
- 2020-05-08 JP JP2021566278A patent/JP7760377B2/ja active Active
- 2020-05-08 SG SG11202112399PA patent/SG11202112399PA/en unknown
- 2020-05-08 CN CN202080048983.XA patent/CN114430745A/zh active Pending
-
2021
- 2021-11-08 IL IL287928A patent/IL287928A/en unknown
-
2025
- 2025-05-07 JP JP2025077567A patent/JP2025120179A/ja active Pending
- 2025-07-25 AU AU2025208511A patent/AU2025208511A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Franklin | STRUCTURAL STUDIES OF HUMAN 7S γ-GLOBULIN (G IMMUNOGLOBULIN) Further Observations of a Naturally Occurring Protein Related to the Crystallizable (Fast) Fragment | |
| TWI596107B (zh) | 單株抗體之新穎純化方法 | |
| TWI913830B (zh) | 微晶片毛細管電泳分析及試劑 | |
| JP2025109759A5 (cg-RX-API-DMAC7.html) | ||
| RU2580020C2 (ru) | Способ снижения гетерогенности антител и способ получения соответствующих антител | |
| JPH09506001A (ja) | 異種二重特異性抗体の製造法 | |
| EP3966238A2 (en) | Variant domains for multimerizing proteins and separation thereof | |
| JP7817743B2 (ja) | タンパク質の精製の改善されたプロセス | |
| US20200377560A1 (en) | Antibodies to royalactin and uses thereof | |
| US20230049176A1 (en) | Methods to decrease impurities from recombinant protein manufacturing processes | |
| TWI872049B (zh) | 生成包含有兩種或更多種抗體的組成物之技術 | |
| NZ782091B2 (en) | Variant domains for multimerizing proteins and separation thereof | |
| Gugerli et al. | Etiological studies and diagnosis of grapevine leafroll disease improved by monoclonal antibodies | |
| US20260117000A1 (en) | Process of purification of protein | |
| US10308716B2 (en) | Method for producing polyclonal antibodies using an antigenic composition comprising protein-containing membrane vesicles | |
| US20260116917A1 (en) | Process of purification of protein | |
| JP2004081042A (ja) | タンパク質溶液の調製方法、当該タンパク質溶液、当該タンパク質溶液を利用したモノクローナル抗体の作製方法及び当該モノクローナル抗体 | |
| JP3858945B2 (ja) | ハイブリドーマの選抜方法 | |
| JP2024521871A (ja) | マイクロチップキャピラリー電気泳動アッセイ及び試薬 | |
| CN114409798A (zh) | 制备包含两种或更多种抗体的组合物 | |
| TW202445126A (zh) | 基於質譜法之體內共表現抗體之表徵 | |
| CN113439090A (zh) | 制备包含两种或更多种抗体的组合物 | |
| KR20250025373A (ko) | 하류 항체 정제에서 uf/df 풀로부터의 집합체의 클리어런스 | |
| CN120775035A (zh) | 特异性单克隆抗体及其在猴痘病毒检测、中和的应用 | |
| RU2024139941A (ru) | Способы очистки полиспецифических антител |